• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃滞留给药系统的现状与未来展望

Current State and Future Perspectives on Gastroretentive Drug Delivery Systems.

作者信息

Tripathi Julu, Thapa Prakash, Maharjan Ravi, Jeong Seong Hoon

机构信息

College of Pharmacy, Dongguk University-Seoul, 32 Donggukro, Ilsandonggu, Goyang, Gyeonggi 10326, Korea.

出版信息

Pharmaceutics. 2019 Apr 20;11(4):193. doi: 10.3390/pharmaceutics11040193.

DOI:10.3390/pharmaceutics11040193
PMID:31010054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6523542/
Abstract

In recent years, many attempts have been made to enhance the drug bioavailability and therapeutic effectiveness of oral dosage forms. In this context, various gastroretentive drug delivery systems (GRDDS) have been used to improve the therapeutic efficacy of drugs that have a narrow absorption window, are unstable at alkaline pH, are soluble in acidic conditions, and are active locally in the stomach. In this review, we discuss the physiological state of the stomach and various factors that affect GRDDS. Recently applied gastrointestinal technologies such as expandable, superporous hydrogel; bio/mucoadhesive, magnetic, ion-exchange resin; and low- and high-density-systems have also been examined along with their merits and demerits. The significance of in vitro and in vivo evaluation parameters of various GRDDS is summarized along with their applications. Moreover, future perspectives on this technology are discussed to minimize the gastric emptying rate in both the fasted and fed states. Overall, this review may inform and guide formulation scientists in designing the GRDDS.

摘要

近年来,人们进行了许多尝试来提高口服剂型的药物生物利用度和治疗效果。在此背景下,各种胃滞留给药系统(GRDDS)已被用于提高吸收窗窄、在碱性pH值下不稳定、在酸性条件下可溶且在胃中局部起作用的药物的治疗效果。在本综述中,我们讨论了胃的生理状态以及影响GRDDS的各种因素。最近应用的胃肠道技术,如可膨胀的超多孔水凝胶、生物/粘膜粘附性、磁性、离子交换树脂以及低密度和高密度系统,也已连同它们的优缺点进行了研究。总结了各种GRDDS的体外和体内评价参数的意义及其应用。此外,还讨论了该技术的未来展望,以尽量降低禁食和进食状态下的胃排空率。总体而言,本综述可为制剂科学家设计GRDDS提供参考和指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/6010e5e597f9/pharmaceutics-11-00193-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/1833c6e78109/pharmaceutics-11-00193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/37831640f5cb/pharmaceutics-11-00193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/752f472b5004/pharmaceutics-11-00193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/d5deadaa7688/pharmaceutics-11-00193-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/3a4c73b54a17/pharmaceutics-11-00193-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/6010e5e597f9/pharmaceutics-11-00193-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/1833c6e78109/pharmaceutics-11-00193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/37831640f5cb/pharmaceutics-11-00193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/752f472b5004/pharmaceutics-11-00193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/d5deadaa7688/pharmaceutics-11-00193-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/3a4c73b54a17/pharmaceutics-11-00193-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a1ed/6523542/6010e5e597f9/pharmaceutics-11-00193-g006.jpg

相似文献

1
Current State and Future Perspectives on Gastroretentive Drug Delivery Systems.胃滞留给药系统的现状与未来展望
Pharmaceutics. 2019 Apr 20;11(4):193. doi: 10.3390/pharmaceutics11040193.
2
Overview on gastroretentive drug delivery systems for improving drug bioavailability.概述改善药物生物利用度的胃滞留型药物传递系统。
Int J Pharm. 2016 Aug 20;510(1):144-58. doi: 10.1016/j.ijpharm.2016.05.016. Epub 2016 May 9.
3
An Insight on Novel Approaches & Perspectives for Gastro-Retentive Drug Delivery Systems.新型胃滞留药物传递系统的方法和观点的深入探讨。
Curr Drug Deliv. 2023;20(6):708-729. doi: 10.2174/1567201819666220819200236.
4
Features and Facts of a Gastroretentive Drug Delivery System-A Review.胃滞留给药系统的特点与现状——综述
Turk J Pharm Sci. 2022 Aug 31;19(4):476-487. doi: 10.4274/tjps.galenos.2021.44959.
5
An Overview on Various Approaches and Recent Patents on Gastroretentive Drug Delivery Systems.胃滞留给药系统的各种方法及近期专利概述
Recent Pat Drug Deliv Formul. 2018;12(2):84-92. doi: 10.2174/1872211312666180308150218.
6
Gastroretentive drug delivery systems: current developments in novel system design and evaluation.胃滞留型药物传递系统:新型系统设计与评估的最新进展。
Curr Drug Deliv. 2009 Oct;6(5):451-60. doi: 10.2174/156720109789941687.
7
Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.胃滞留型制剂:综述,特别强调漂浮型药物传递系统。
Drug Deliv. 2011 Feb;18(2):97-110. doi: 10.3109/10717544.2010.520354. Epub 2010 Oct 20.
8
Gastroretentive floating drug-delivery systems: a critical review.胃滞留型漂浮给药系统:综述
Crit Rev Ther Drug Carrier Syst. 2011;28(1):47-99. doi: 10.1615/critrevtherdrugcarriersyst.v28.i1.20.
9
Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?使用胃滞留技术靶向作用于上消化道的药物研究数十年:我们目前处于什么阶段?
Drug Deliv. 2016;23(2):378-94. doi: 10.3109/10717544.2014.936535. Epub 2014 Jul 15.
10
Gastroretentive drug delivery systems for therapeutic management of peptic ulcer.用于消化性溃疡治疗管理的胃滞留药物递送系统
Crit Rev Ther Drug Carrier Syst. 2014;31(6):531-57. doi: 10.1615/critrevtherdrugcarriersyst.2014011104.

引用本文的文献

1
Albumin-Based Cryogels as Floating Platforms for Gastroretentive Drug Delivery Applications.基于白蛋白的冷冻凝胶作为用于胃滞留药物递送应用的漂浮平台。
ACS Omega. 2025 Aug 13;10(33):37639-37649. doi: 10.1021/acsomega.5c04153. eCollection 2025 Aug 26.
2
Fabrication of Cellulose Derivatives-Based Highly Porous Floating Tablets for Gastroretentive Drug Delivery via Sugar Templating Method.通过糖模板法制备用于胃滞留药物递送的基于纤维素衍生物的高孔隙率漂浮片。
Polymers (Basel). 2025 Feb 12;17(4):485. doi: 10.3390/polym17040485.
3
Gastroretentive microballoons of olmesartan medoxomil: formulation and evaluation.

本文引用的文献

1
Effects of Formulation and Process Variables on Gastroretentive Floating Tablets with A High-Dose Soluble Drug and Experimental Design Approach.制剂和工艺变量对含高剂量可溶性药物的胃滞留漂浮片的影响及实验设计方法
Pharmaceutics. 2018 Sep 17;10(3):161. doi: 10.3390/pharmaceutics10030161.
2
Rheological and mucoadhesive properties of polysaccharide from Bletilla striata with potential use in pharmaceutics as bio-adhesive excipient.具有用作药剂学生物黏附赋形剂潜力的白及多糖的流变性和黏膜黏附特性。
Int J Biol Macromol. 2018 Dec;120(Pt A):529-536. doi: 10.1016/j.ijbiomac.2018.08.127. Epub 2018 Aug 27.
3
Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics.
奥美沙坦酯胃滞留微球:制剂与评价
Ther Deliv. 2025 Mar;16(3):227-236. doi: 10.1080/20415990.2025.2466418. Epub 2025 Feb 25.
4
Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage.通过工程噬菌体在哺乳动物肠道中实现蛋白质的持续原位产生和释放。
Nat Biotechnol. 2025 Feb 18. doi: 10.1038/s41587-025-02570-7.
5
A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies.口服给药系统中的挑战及创新设计策略的最新进展综述
Curr Pharm Des. 2025;31(5):360-376. doi: 10.2174/0113816128338560240923073357.
6
Gastroretentive Delivery Approach to Address pH-Dependent Degradation of (+)- and (-)-Phenserine.解决(+)-和(-)-苯丁氮酸对 pH 依赖性降解的胃滞留递药方法。
AAPS PharmSciTech. 2024 Aug 27;25(7):198. doi: 10.1208/s12249-024-02903-w.
7
Expanding the Manufacturing Approaches for Gastroretentive Drug Delivery Systems with 3D Printing Technology.利用3D打印技术拓展胃滞留药物递送系统的制造方法
Pharmaceutics. 2024 Jun 11;16(6):790. doi: 10.3390/pharmaceutics16060790.
8
Nanofabrication of Losartan Potassium Sustained Release Floating Microspheres using Different Grades of Ethyl Cellulose and its Insight on Release Profiles.采用不同等级乙基纤维素的氯沙坦钾控释漂浮微球的纳米制备及其对释放谱的影响。
Curr Pharm Des. 2024;30(28):2257-2265. doi: 10.2174/0113816128309675240530060752.
9
Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function.新型缓释普瑞巴林片剂在肾功能减退受试者中的药代动力学特性
Transl Clin Pharmacol. 2023 Dec;31(4):226-237. doi: 10.12793/tcp.2023.31.e20. Epub 2023 Dec 20.
10
Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets.用于盐酸普萘洛尔片的熔融沉积成型3D打印胃滞留漂浮装置
Polymers (Basel). 2023 Aug 26;15(17):3554. doi: 10.3390/polym15173554.
制备和评价含有普瑞巴林的非泡腾型胃滞留片用于每日一次给药和剂量比例药代动力学。
Int J Pharm. 2018 Oct 25;550(1-2):160-169. doi: 10.1016/j.ijpharm.2018.08.038. Epub 2018 Aug 20.
4
Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems.三维打印技术与压缩片剂相结合,用于制备核黄素漂浮片-装置(TiD)系统。
Int J Pharm. 2018 Oct 5;549(1-2):370-379. doi: 10.1016/j.ijpharm.2018.08.011. Epub 2018 Aug 11.
5
A QbD approach for the fabrication of immediate and prolong buoyant cinnarizine tablet using polyacrylamide-g-corn fibre gum.采用聚丙烯酰胺-g-玉米纤维胶制备即刻和持续漂浮型肉桂嗪片的 QbD 方法。
Int J Biol Macromol. 2018 Oct 1;117:350-361. doi: 10.1016/j.ijbiomac.2018.05.178. Epub 2018 May 25.
6
Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.胃滞留筏型液体给送系统——一种新的载体介导药物释放延长方法
Drug Deliv. 2018 Nov;25(1):1161-1174. doi: 10.1080/10717544.2018.1474969.
7
Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.设计和优化普瑞巴林胃漂浮型缓释片:体外和体内评价。
Int J Pharm. 2018 Jul 10;545(1-2):37-44. doi: 10.1016/j.ijpharm.2018.04.011. Epub 2018 Apr 9.
8
Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery.具有嵌入式脂质体的粘弹性藻酸盐糊剂用于局部口腔药物递送。
Int J Biol Macromol. 2018 May;111:62-69. doi: 10.1016/j.ijbiomac.2017.12.137. Epub 2017 Dec 29.
9
Release kinetics of highly porous floating tablets containing cilostazol.含西洛他唑的高孔隙率漂浮片的释放动力学
Eur J Pharm Biopharm. 2017 Jun;115:39-51. doi: 10.1016/j.ejpb.2017.01.027. Epub 2017 Feb 20.
10
Effect of gel formation on the dissolution behavior of clarithromycin tablets.凝胶形成对克拉霉素片溶出行为的影响。
Int J Pharm. 2017 Apr 15;521(1-2):33-39. doi: 10.1016/j.ijpharm.2017.01.065. Epub 2017 Feb 11.